|
KRAS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.32989999999966E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.424100E-03 |
| Normal-vs-Stage2 |
8.077600E-02 |
| Normal-vs-Stage3 |
1.68286999999712E-05 |
| Normal-vs-Stage4 |
3.95500000005544E-06 |
| Stage1-vs-Stage2 |
9.904400E-01 |
| Stage1-vs-Stage3 |
1.012300E-02 |
| Stage1-vs-Stage4 |
9.395400E-03 |
| Stage2-vs-Stage3 |
1.356560E-01 |
| Stage2-vs-Stage4 |
1.256990E-01 |
| Stage3-vs-Stage4 |
8.594600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.399850E-04 |
| Normal-vs-AfricanAmerican |
3.14719999949808E-07 |
| Normal-vs-Asian |
7.625400E-01 |
| Caucasian-vs-AfricanAmerican |
6.676000E-03 |
| Caucasian-vs-Asian |
3.640200E-01 |
| AfricanAmerican-vs-Asian |
2.400500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.07430000001663E-06 |
| Normal-vs-Female |
1.699790E-02 |
| Male-vs-Female |
2.295600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.604800E-04 |
| Normal-vs-Age(41-60Yrs) |
8.573300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.436500E-04 |
| Normal-vs-Age(81-100Yrs) |
1.143510E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.535550E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.429400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.794000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.461400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.260800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.493800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.773800E-01 |
| Normal-vs-Grade 2 |
4.180400E-02 |
| Normal-vs-Grade 3 |
4.35620000072134E-08 |
| Normal-vs-Grade 4 |
1.34109999994081E-07 |
| Grade 1-vs-Grade 2 |
7.205000E-01 |
| Grade 1-vs-Grade 3 |
3.898300E-02 |
| Grade 1-vs-Grade 4 |
2.158100E-02 |
| Grade 2-vs-Grade 3 |
3.973100E-04 |
| Grade 2-vs-Grade 4 |
9.90250000000303E-05 |
| Grade 3-vs-Grade 4 |
8.983700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.027400E-01 |
| Normal-vs-ccB subtype |
1.77521999999986E-05 |
| ccA subtype-vs-ccB subtype |
2.550100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.954100E-04 |
| Normal-vs-N1 |
2.374100E-02 |
| N0-vs-N1 |
6.398400E-01 |
|
|
